12 min modelled half-life, peaking 6 min after a dose. What that means for how long it lasts, how much it builds up, and when bloodwork is worth drawing.
Sermorelin's twelve-minute half-life is the shortest on this site by an order of magnitude, and it is not an approximation of a longer-acting drug — it is native biology. Sermorelin is simply the first twenty-nine amino acids of human GHRH, the fragment that carries all the receptor activity, with nothing added to protect it. The enzyme DPP-4 begins dismantling it almost immediately, exactly as it does the body's own GHRH.
Every other GHRH analogue on this site is an attempt to lengthen that number. Tesamorelin adds a group at the N-terminus and buys tens of minutes; CJC-1295 without DAC substitutes four amino acids and reaches half an hour; CJC-1295 with DAC binds albumin and reaches a week. Sermorelin is the unmodified baseline they are all measured against, which makes it the most physiological of them and the most demanding to use — a compound with a twelve-minute half-life is entirely dependent on timing.
There is no accumulation to discuss and no steady state: a dose is a single pulse, gone within the hour. What makes that a feature rather than a limitation is the pituitary's feedback loop, which stays intact — GHRH signalling this brief cannot override somatostatin, so the growth hormone response remains self-limiting in a way exogenous growth hormone is not. That is the argument for a secretagogue over the hormone itself, and the short half-life is the mechanism behind it. Sermorelin's monitoring in the app is IGF-1 quarterly plus fasting glucose, which reflects that the marker worth watching moves over weeks even though the drug is measured in minutes.
pkCurve function — a
one-compartment absorption-and-elimination model with the absorption rate fitted so the
peak lands at the published time to peak.Charted at once daily because that is the once-daily pre-bed schedule in the app's own dosing rows. It is what the numbers below are indexed to, not a recommendation about frequency — that is a prescribing decision.
The accumulation ratio is a closed form; the peak-to-trough figure is not. The generator adds up enough repeated curves for the total to stop changing, then reads the highest and lowest points of the last interval — which is what steady state means in practice. The vertical axis is relative, not a concentration: the shape and the ratios carry across people, the absolute levels do not.
Off-label or community practice Reproduced from the app's entry so you can see what the chart above is indexed to. Which row applies to a particular person, if any, is a clinical decision this page does not make.
| Label | Amount | Route and frequency |
|---|---|---|
| Standard | 200-300mcg | Once daily before bed SubQ fasted |
| With GHRP | Sermorelin 200mcg + Ipamorelin 200mcg | Once or twice daily fasted |
The panel the app records for Sermorelin is: IGF-1 at baseline and every 3 months. Fasting glucose.. The pharmacokinetic point is the timing rather than the list: after any change, a level takes about 1 h to settle, so a panel drawn sooner measures something still moving. And because this compound clears completely between doses, a serum level says only what the last few hours did — which is why the marker worth following here is a downstream one measured over weeks, not the compound itself. Whether a result means anything is a question for the clinician who ordered it, read against the reference range your own lab printed. The lab-marker pages cover what the individual analytes measure.
Related: the interactive half-life calculator to try other cadences.
The app draws this curve from the doses you actually logged — your dates, your cadence — and projects seven days forward from the last one.
Save this dose to your log